Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Disulfide bonds are covalent linkages formed between cysteine residues within and between mucin monomers. These bonds are crucial for the oligomerization of mucins into large polymeric networks, which are essential for forming the viscoelastic mucus gel in airway secretions. The formation and reduction of these bonds regulate mucus expansion, viscosity, and overall barrier function in the respiratory tract. Targeting these bonds is a therapeutic strategy for modulating mucus properties in airway diseases.
Reduction of disulfide bonds, leading to decreased mucus viscosity.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mucin Disulfide Bonds.